Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
May 27, 2024
Gut Microbiome Multi-Omics and Cognitive Function in the Hispanic Community Health Study/Study of Latinos- Investigation of Neurocognitive Aging
Natalia Palacios, Scott Gordon, Tao Wang, et al.
Blood
|
May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
Paul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Leukemia & Lymphoma
|
July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide
Dana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Leukemia & Lymphoma
|
January 15, 2016
Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
Robert M Rifkin, Rafat Abonour, Jatin J Shah, et al.
Mayo Clinic Proceedings
|
July 13, 2004
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity
Paul Richardson, Robert Schlossman, Sundar Jagannath, et al.
Cancer Medicine
|
April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide
Dana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Epilepsy & Behavior : E&B
|
November 20, 2012
Proceedings of the Third International Workshop on Advances in Electrocorticography
Anthony Ritaccio, Michael Beauchamp, Conrado Bosman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network
Antonio Palumbo, Patrizia Falco, Paolo Corradini, et al.
American Journal of Hematology
|
November 26, 2013
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
Aleksandr Lazaryan, Mohamad A Hussein, Frederic J Reu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Dementia Care Research and Psychosocial Factors
Dean Ornish, Catherine Madison, Miia Kivipelto, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Medrxiv : the Preprint Server for Health Sciences
|
May 27, 2024
Gut Microbiome Multi-Omics and Cognitive Function in the Hispanic Community Health Study/Study of Latinos- Investigation of Neurocognitive Aging
Natalia Palacios, Scott Gordon, Tao Wang, et al.
Blood
|
May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
Paul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Leukemia & Lymphoma
|
July 19, 2016
Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide
Dana E Rollison, Rami Komrokji, Ji-Hyun Lee, et al.
Leukemia & Lymphoma
|
January 15, 2016
Connect MM® - the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
Robert M Rifkin, Rafat Abonour, Jatin J Shah, et al.
Mayo Clinic Proceedings
|
July 13, 2004
Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: results of an open-label multicenter phase 2 study of efficacy, toxicity, and biological activity
Paul Richardson, Robert Schlossman, Sundar Jagannath, et al.
Cancer Medicine
|
April 22, 2016
Subsequent primary malignancies and acute myelogenous leukemia transformation among myelodysplastic syndrome patients treated with or without lenalidomide
Dana E Rollison, Kenneth H Shain, Ji-Hyun Lee, et al.
Epilepsy & Behavior : E&B
|
November 20, 2012
Proceedings of the Third International Workshop on Advances in Electrocorticography
Anthony Ritaccio, Michael Beauchamp, Conrado Bosman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2007
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network
Antonio Palumbo, Patrizia Falco, Paolo Corradini, et al.
American Journal of Hematology
|
November 26, 2013
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma
Aleksandr Lazaryan, Mohamad A Hussein, Frederic J Reu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Dementia Care Research and Psychosocial Factors
Dean Ornish, Catherine Madison, Miia Kivipelto, et al.
Page
of 7